Leonardo Victor de Knegt serves as an Associate Professor in the Department of Veterinary and Animal Sciences at the Faculty of Health and Medical Sciences, University of Copenhagen. His research centers on animal welfare and disease control within livestock production systems, with particular expertise in swine nutrition, gastrointestinal health, and veterinary epidemiology. Dr. de Knegt's research program investigates critical challenges in modern livestock farming, including optimizing piglet development through dietary interventions (e.g., benzoic acid and lactose supplementation), mitigating stress in gestating sows, and enhancing disease surveillance in cattle populations. His work integrates molecular biology, nutritional science, and advanced statistical modeling to address complex interactions between feed composition, animal physiology, and production outcomes. Key methodologies include gene expression analysis, state space modeling for dairy herd management, and genomic contact-tracing for infectious disease control. Analysis of his 2020-2025 publications reveals a cohesive research trajectory focused on improving animal health through nutritional innovation and precision monitoring. Dominant themes include feed additive efficacy in neonatal piglets, risk factor identification for reproductive challenges in hyperprolific sows, and computational approaches to dairy farm management. His collaborative network spans multiple University of Copenhagen departments and international research teams, consistently targeting practical solutions for sustainable livestock production. Dr. de Knegt maintains an active publication record with 34 research outputs including 22 peer-reviewed journal articles. His work appears in high-impact journals such as Animals , Journal of Dairy Science , and Preventive Veterinary Medicine , demonstrating significant contributions to veterinary science methodology and livestock welfare applications.
Oliver James Hulme serves as Associate Professor in the Department of Psychology within the Faculty of Social Sciences at the University of Copenhagen. His office is located at Øster Farimagsgade 2A, 1350 København K, with scheduled office hours on Thursdays from 12:00-13:00. His research focuses on: Reward decision-making risk-taking neuroeconomics functional neuroimaging Bayesian modelling cognitive computational neuroscience open science Publications from 2013-2024 demonstrate sustained investigation into neural mechanisms of decision processes, particularly in Parkinson's disease, aging populations, and eating disorders. His methodology integrates fMRI, computational modeling, and behavioral paradigms to examine risk assessment, neural connectivity, and cognitive control under varying physiological states. No scientific awards were documented in the source material. Details regarding student supervision, grant funding, and laboratory infrastructure were not provided in the available information.
Joachim Størling is an Affiliated Associate Professor at the Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, and a Senior Researcher and Team Leader at the Department of T1D Biology, Steno Diabetes Center Copenhagen. His research focuses on advancing understanding of type 1 diabetes pathophysiology, particularly beta-cell destruction mechanisms and therapeutic interventions to preserve insulin production. His educational background includes: PhD in Health Sciences, University of Copenhagen (2005) MSc in Biology, University of Copenhagen (2001) BSc in Molecular Biology, Roskilde University (1998) Størling's research centers on three interconnected areas: functional genomics to identify causal type 1 diabetes genes operating in beta-cells; deciphering pro-inflammatory cytokine signaling in beta-cell apoptosis; and exploring incretin hormone biology (GLP-1/GIP) for beta-cell protection. His translational approach combines clinical samples, human islets, and animal models to bridge molecular mechanisms with therapeutic applications. Recent publications (2024-2025) demonstrate a strong clinical-molecular synergy, with emphasis on incretin-based therapies (liraglutide, GIP), time-restricted eating interventions, and probiotic approaches. These studies consistently target beta-cell preservation in type 1 diabetes while exploring biomarkers for disease progression and remission. His scientific awards include: Rising Star Award, University Hospital Herlev (2014) Postdoc Award, Independent Research Fund Denmark (2006) Størling has secured over 13 million DKK in research funding as principal investigator, including two major Independent Research Fund Denmark grants (2013, 2017). He serves as a reviewer for leading journals (The Lancet Diabetes & Endocrinology, Diabetologia) and international grant agencies (JDRF, Diabetes UK), and co-founded the CPH-DIRECT diabetes research consortium. He leads a dedicated research team at Steno Diabetes Center Copenhagen focusing on beta-cell biology in type 1 diabetes, with active participation in national and international collaborative networks exploring diabetes pathophysiology and therapeutic innovation.
Jesper Hastrup Svendsen serves as Clinical Professor of Cardiology and Head of Department at the University of Copenhagen's Faculty of Health and Medical Sciences, Department of Clinical Medicine. He maintains a clinical consultant role at the Heart Center, Copenhagen University Hospital – Rigshospitalet. His academic foundation includes an MD from the University of Copenhagen (1983) and a Doctor of Medical Sciences (dr.med.) degree (1994), with board certification in General Internal Medicine and Cardiovascular Diseases. Dr. Svendsen's research centers on cardiac arrhythmias with specific expertise in atrial fibrillation, ion channel diseases, and genetic/inflammatory mechanisms. His clinical work focuses on arrhythmia management including device implantation (pacemakers, ICDs, CRTs) and pharmacological interventions. His educational background in cardiology and internal medicine informs his dual approach to clinical care and research innovation. Analysis of his recent publications reveals a strong emphasis on atrial fibrillation screening methodologies (particularly through the LOOP study), device-based monitoring technologies, and the intersection of metabolic disorders with cardiac arrhythmias. His work spans clinical trials, consensus guidelines, and translational research with significant contributions to European cardiology standards. Dr. Svendsen actively secures research funding through major initiatives including the SafeHeart study (Horizon 2020) and LOOP study (Innovation Fund Denmark), while serving on multiple grant committees. His industry collaborations with Medtronic, Vital Beats, and pharmaceutical companies support technology development and clinical implementation. He maintains leadership roles through advisory board positions and textbook authorship (Medicinsk Kompendium), driving knowledge dissemination in cardiology. His institutional affiliations and research networks demonstrate sustained impact across clinical practice, academic research, and medical education domains.
Søren Saxmose Nielsen is a Professor in Disease and Diagnostic Modelling at the Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen. He specializes in veterinary epidemiology with a focus on infectious diseases of production animals, particularly paratuberculosis. Dr. Nielsen serves as Chair of the Animal Health and Welfare Panel and as a member of the Scientific Committee in the European Food Safety Authority (EFSA). Dr. Nielsen received his veterinary degree from The Royal Veterinary and Agricultural University (KVL), Denmark, in 1998. He earned his PhD in Veterinary Epidemiology in 2002 based on studies relating to interpretation of diagnostic test information for bovine paratuberculosis. He obtained his DVSc title from the University of Copenhagen in 2009 based on studies used for design of the Danish control programme on paratuberculosis. He also holds a Diplomate from the European College of Veterinary Public Health (awarded 2006). Dr. Nielsen's primary research interests focus on animal health and welfare, infectious diseases of production animals, and zoonoses. His work has particularly emphasized the diagnosis, control and epidemiology of paratuberculosis, for which he designed the Danish control programme successfully implemented in 2006. Current research projects include the impact of infectious diseases on animal welfare, health and welfare of unowned cats, animal welfare at slaughter, risk of disease introduction and spread, and uncertainty in diagnostic methods. His recent publications show a strong focus on animal welfare across various species, disease control strategies, and risk assessment methodologies. Dr. Nielsen has published over 190 peer-reviewed articles in international scientific journals, along with more than 80 professional papers and numerous conference contributions. His work with EFSA has resulted in over 150 international reports including guidance on methodology and development of legislation in the European Union. Dr. Nielsen collaborates with Danish stakeholders in animal production, the pharmaceutical industry, and animal welfare NGOs through the veterinary consultancy unit and research projects. He serves as Chair of the Panel on Animal Health and Welfare and the Scientific Committee in EFSA, receiving a salary according to EFSA's Expert's Compensation Guide.
Katrine Laura Rasmussen is a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Her work spans both Clinical Biochemistry and medical research with dual institutional affiliations at Dyrehavevej 29, 3400 Hillerød and Blegdamsvej 3, 2200 København N. Her research interests focus on the intersection of genetics, neurodegenerative disorders, and cardiovascular disease, with particular expertise in apolipoprotein E (APOE) research. Dr. Rasmussen's work explores genetic risk factors for Alzheimer's disease, cardiovascular conditions, and their interrelationships, contributing significantly to understanding disease mechanisms and risk prediction. Analysis of her recent publications reveals a strong emphasis on population-based genetic studies, risk assessment methodologies, and translational research connecting laboratory findings with clinical applications. Her work frequently appears in high-impact journals across neurology, cardiology, and genetics disciplines, demonstrating interdisciplinary collaboration across international research teams. Dr. Rasmussen has received significant research attention, with her work being picked up by numerous news outlets and shared extensively across academic social media platforms. Several of her publications have garnered substantial attention on Mendeley, indicating their importance to the research community.
Mustafa Bulut serves as Clinical Associate Professor at the University of Copenhagen's Faculty of Health and Medical Sciences within the Department of Clinical Medicine. His clinical and research activities are centered at Regionshospitalet Køge and Rigshospitalet in Copenhagen, with affiliations to both surgical and gastrointestinal research units. His research focuses on innovative approaches in colorectal cancer management, including electroporation therapy, AI-assisted endoscopic diagnostics, and hybrid surgical techniques. Key areas include neoadjuvant immunotherapy trials, mortality prediction models using data-driven approaches, and development of novel endoscopic procedures for high-risk patients. His work bridges clinical practice with technological innovation in gastrointestinal medicine. Recent publications demonstrate strong emphasis on translational research, with multiple studies on calcium electroporation for tumor ablation and AI applications in colonoscopy. His collaborative network includes prominent Danish surgical oncology centers and international research groups focused on improving colorectal cancer outcomes through technological integration. Professor Bulut maintains active clinical practice while contributing to medical literature through high-impact publications in surgical oncology and endoscopy journals. His current research trajectory shows increasing focus on data science applications in surgical decision-making and minimally invasive cancer treatment modalities.
Merete Labriola serves as a Professor in the Department of Public Health, Section of Social Medicine, at the University of Copenhagen, Denmark, with contact details including phone +45 35 33 31 32 and email merete.labriola@sund.ku.dk at Gothersgade 160, 3., 1123 København K. Her research spans Occupational Health, Public Health, and Social Medicine, with specialized focus on return-to-work dynamics, long-term sickness absence predictors, disability pension risk factors, and psychosocial work environment impacts. Key methodologies include prospective cohort studies leveraging Danish national registers like DREAM to examine socioeconomic gradients and individual behavioral influences on work disability outcomes. Analysis of her 9 publications (2006-2019) reveals consistent investigation into administrative data as predictive markers for disability, multilevel workplace risk factors, and cross-cultural instrument validation. Her work demonstrates strong policy relevance with multiple citations in governmental sources and significant academic impact evidenced by citation counts exceeding 140 in occupational health journals.
Maj Vinberg is a Clinical Professor at the Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, specializing in Psychiatry. Based at Blegdamsvej 3, 2200 Copenhagen N, Denmark, she holds an ORCID (0000-0002-5982-1335) and maintains clinical-academic roles with Region Hovedstaden (email: maj.vinberg@regionh.dk, phone: +4538643227). Her educational qualifications include: MD DMSc PhD Vinberg's research centers on mood disorders through longitudinal twin studies investigating cognitive predictors, biomarkers, and treatment outcomes. Key interests include bipolar disorder pathophysiology, cognitive functioning in affective episodes, pharmacovigilance of antidepressants, and virtual reality assessment tools. Her work integrates genetic vulnerability with environmental factors like lifestyle and metabolic health. Analysis of her 2025 publications reveals dominant themes: 1) Twin-based prediction models for mood disorder onset/recurrence using cognitive and personality metrics; 2) Neuroimaging and biomarker studies (e.g., erythropoietin effects on brain structure, malondialdehyde as oxidative stress marker); 3) Pharmacovigilance investigations linking antidepressants to ocular complications; 4) Digital phenotyping via virtual reality for functional assessment. Scientific recognition: No awards explicitly documented in source material Collaborative networks with Kessing, Miskowiak, and Nordentoft drive her research program, though specific grant details and advised students aren't disclosed in available information. Her departmental affiliation indicates integration within Copenhagen's psychiatric research infrastructure.
Johan Michael Burisch serves as a Clinical Professor at the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen, holding a dual appointment with the Capital Region of Denmark. He is also a chief physician at Amager and Hvidovre Hospital's Gastrounit and holds the title of Doctor of Medical Sciences (dr.med.). Dr. Burisch's research program centers on inflammatory bowel diseases (IBD), where he integrates epidemiology, multi-omics approaches, and individualized treatment strategies. His work includes leading large-scale studies like the ECCO-EpiCom project to explore global and regional differences in IBD incidence and prevalence. He combines genetic, microbiome, and proteomic data to identify molecular subgroups of IBD, improving disease prognosis and advancing personalized treatment approaches. His research also investigates IBD natural history, complications including colorectal cancer, and develops predictive tools to enhance patient outcomes through multidisciplinary care models and eHealth solutions. Analysis of his recent publications reveals a strong focus on dietary quality in IBD patients, cancer risks in polyposis syndromes, biomarkers for disease monitoring, anti-TNF treatment outcomes, novel drug formulations for ulcerative colitis, and evidence-based clinical guidelines. These works span multiple disciplines including gastroenterology, epidemiology, biomarker research, clinical trial design, and healthcare economics. UEG National Scholar Award (Best from Denmark) (2012, 2017) ECCO Presidential Price for young investigators (2013) The Lundbeck Foundation's Talent Price (2014) Jakobinerklubbens hædersmedajle (2014) ECCO Mark of Merit (2016) UEG Rising star award (2019) ECCO Young Researcher Award – Clinical/translational science (2023) Erhoff Fondens Talentpris (2024) Dr. Burisch currently supervises 5 medical students and 7 PhD students. His research program is supported by substantial funding including AbbVie (1.2 million €), Takeda Pharma (400,000 €), and Novo Nordisk Foundation (8 million € for a Challenge grant). He leads multiple major research initiatives including the Danish Inflammatory bowel disease Biobank (DIB), EPI-IBD, and The INCEPTION study. As an associate editor for the Journal of Crohn's and Colitis and editorial board member for Gut and Alimentary Pharmaceuticals and Therapeutics, he plays a significant role in shaping the scientific discourse in his field. He is actively involved in professional organizations including the European Crohn's & Colitis Organization (Guideline Committee 2024-2027) and United European Gastroenterology.
Stig Bernt Poulsen is a Professor in the Department of Psychology at the University of Copenhagen, where he has been employed since 1995. He currently serves as the coordinator of the Center for Psychotherapy Research and is the President Elect of the European section of the Society for Psychotherapy Research. His academic career at the University of Copenhagen has progressed from Research Assistant (1995-1999) to Assistant Professor (2000-2002), Associate Professor (2002-2020), and finally Professor (2020-present). He has extensive experience in clinical psychology research and practice, with a particular focus on psychotherapy effectiveness and process. Dr. Poulsen earned his PhD in Psychology from the University of Copenhagen in 2000 and his MSc in Psychology from the same institution in 1989. His early career included clinical work as a psychologist at the Copenhagen Student Counselling Centre (1990-1995) and a trainee position at the Adult Psychiatric Ward of Copenhagen University Hospital (1989-1990). Professor Poulsen's primary research focuses on psychotherapy from multiple perspectives, with special emphasis on eating disorders (particularly bulimia nervosa), client experience of psychotherapy, practice-oriented research in psychotherapy, and psychological assessment. He has conducted numerous randomized controlled trials comparing different therapeutic approaches, most notably the Copenhagen Bulimia Trial which compared psychoanalytic psychotherapy and cognitive behavior therapy for bulimia nervosa. His current research includes studies on feedback-informed therapy, rumination-focused CBT for depression, mentalization-based treatment for adolescents with borderline personality disorders, and psychotherapy in the Danish practice sector. He collaborates extensively with the Danish Regions and the Danish Psychological Association on studies of outcome and therapist responsiveness. Analysis of Professor Poulsen's recent publication record reveals a strong focus on borderline personality disorder, particularly in adolescent populations, with numerous longitudinal studies examining treatment outcomes over 5-year periods. There is also significant attention to treatment personalization, with research exploring how client preferences, therapy activities, and their match influence outcomes. His work increasingly incorporates mentalization-based approaches and examines the role of therapeutic alliance and therapist factors in treatment success. The research spans multiple methodologies including randomized controlled trials, qualitative studies, and psychometric validation studies. Professor Poulsen has received major research grants including: 2008: Research grant from the Ivan Nielsen Foundation for Individuals with Particular Mental Disorders (DKK 105,000) 2002: Research grant with Susanne Lunn from the Egmont Foundation (DKK 1,000,000) 2002: Research grant with Susanne Lunn from the Danish Council for Independent Research | Humanities (DKK 2,138,000) As an educator, Professor Poulsen coordinates teaching in clinical psychology at BA and KA levels, delivers lectures and seminars in clinical psychology and psychotherapy, and supervises Master's and PhD theses. He has been actively involved in administration and evaluation, serving as Coordinator of the Centre for Psychotherapy Research since 2013, evaluator of academic positions since 2004, and member of the Study Board at the Department of Psychology (2002-2006). His leadership extends to the international community as President Elect of the European Chapter of the Society for Psychotherapy Research. Professor Poulsen is a key member of several research groups including the Center for Psychotherapy Research and The Copenhagen Bulimia Trial Group at the Department of Psychology, and he plays a leadership role in the European section of the Society for Psychotherapy Research. His work bridges academic research and clinical practice, with strong connections to the Danish mental health system through collaborations with the Danish Regions and the Danish Psychological Association.
Mai-Britt Tolstrup serves as a Clinical Associate Professor at the Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, while simultaneously holding the position of Chief Surgeon at the Department of Surgery, Copenhagen University Hospital NOH since 2021. She maintains a dual appointment between the Capital Region of Denmark and the University of Copenhagen, reflecting her integrated clinical and academic career spanning over 20 years in emergency surgery. Dr. Tolstrup's research interests center on intra- and postoperative surgical strategies, particularly focusing on emergency abdominal procedures. Her work extensively examines patient morbidity and mortality, risk prediction models, and both short- and long-term patient-reported outcomes following emergency surgeries. She has developed significant expertise in areas such as burst abdomen management, small bowel anastomosis techniques, sarcopenia assessment, and delirium prevention protocols in the surgical population. Analysis of her recent publication record (2019-2025) reveals a consistent focus on improving outcomes in emergency abdominal surgery, with particular emphasis on preventing complications like burst abdomen, incisional hernias, and postoperative delirium. Her research demonstrates a methodological evolution from case-control and retrospective cohort studies toward interventional approaches and systematic reviews, indicating maturation of her research program toward evidence-based practice implementation. As a clinical educator and researcher, Dr. Tolstrup has contributed significantly to the understanding of emergency surgical care pathways, with her work being cited extensively across international surgical literature. Her research has practical implications for surgical decision-making, particularly regarding bowel obstruction management, anastomosis techniques in emergency settings, and risk stratification for high-mortality patient populations such as those with liver cirrhosis.
Fran Supek is a Professor at the University of Copenhagen's Faculty of Health and Medical Sciences, where he leads the Genome Data Science laboratory at the Biotech Research & Innovation Centre (BRIC). He also maintains a research group at the IRB Barcelona. Supek is the Principal Investigator of ERC Starting and ERC Consolidator projects, an EMBO Young Investigator, and holds an ICREA tenured professor position (currently on leave). Dr. Supek obtained his PhD in Molecular Biology in 2010 from the University of Zagreb, followed by postdoctoral training at the Centre for Genomic Regulation (CRG) as a Marie Curie fellow. He established his independent laboratory at IRB Barcelona in 2017 as a "Ramón y Cajal" tenure-track fellow, and expanded to BRIC in 2024. His research focuses on statistical genomics and machine learning approaches to study genome stability mechanisms, particularly through analysis of mutation patterns in cancer. The Genome Data Science lab performs large-scale bioinformatic studies of multi-omic data from human tumors, populations, and metagenomes. Key research areas include DNA repair mechanisms, mRNA synthesis and turnover pathways, genetic interactions in cancer genomes, and machine learning approaches for inferring gene function from genomic data. Analysis of Supek's recent publications reveals a strong emphasis on cancer genomics, with particular focus on mutational signatures, DNA repair deficiencies, and the application of artificial intelligence to genomic data analysis. His work spans from fundamental mechanisms of genome instability to translational applications in cancer diagnosis and treatment. ERC Starting Grant recipient ERC Consolidator Grant recipient EMBO Young Investigator ICREA tenured professor (on leave) As Principal Investigator of multiple ERC projects, Supek leads a research program with significant funding for innovative genomic research. His laboratory at BRIC and IRB Barcelona conducts interdisciplinary research combining computational approaches with experimental validation to address fundamental questions in genome biology and cancer evolution. The Genome Data Science lab maintains active collaborations across multiple institutions, with research spanning statistical genomics, machine learning applications in bioinformatics, and experimental validation of computational predictions in cancer biology.
George Napolitano is an Academic employee at the University of Copenhagen's Department of Public Health within the Section of Environmental Health. His work focuses on providing statistical support for various research projects in public health, with particular expertise in cancer screening programs and environmental health research. Dr. Napolitano holds a PhD in Mathematics from the Department of Mathematical Sciences and an MSc in Physics from the University of Naples Federico II. Prior to his current position, he worked as a Postdoc/Researcher at the Centre for Mathematical Sciences from 2013 to 2017, where he conducted research in Theoretical and Mathematical Physics and Applied Probability. His primary research interests include breast cancer screening, cervical cancer screening, HPV vaccination, and allostatic load. His expertise in statistical analysis bridges advanced mathematical methodologies with practical public health applications. Dr. Napolitano has published extensively, with 51 research outputs documented in his profile. His recent publications (2024-2025) demonstrate a strong focus on cervical cancer screening outcomes among HPV-vaccinated women through the Trial23 cohort study, breast cancer screening methodologies including tomosynthesis and deep learning approaches, and environmental health research examining air pollution's impact on lung cancer, respiratory infections, and COVID-19 mortality. His work consistently applies sophisticated statistical methods to address critical questions in epidemiology. Dr. Napolitano maintains an active research profile with multiple publications receiving significant attention from news outlets and academic platforms. His interdisciplinary background in theoretical physics and mathematics provides unique expertise in developing and applying complex statistical models to health data, making substantial contributions to cancer epidemiology and environmental health research.
Rosa Ellen Lavelle-Hill serves as an Assistant Professor of Social Data Science and Psychology within the Faculty of Social Sciences at the University of Copenhagen since March 2023. Her academic appointments include postdoctoral research at the University of Tübingen (Germany) and the Alan Turing Institute (UK). She holds a PhD in "Big Data Psychology" from the University of Nottingham. PhD: Big Data Psychology, University of Nottingham Postdoc: University of Tübingen, Germany Postdoc: Alan Turing Institute, UK Her research integrates psychological theory with big data and machine learning methodologies to analyze human behavior in social good contexts. Key focus areas include sustainable development, environmental psychology, health applications, and migration studies. She specializes in Explainable AI techniques that challenge and refine existing social science theories through data-driven insights. Her methodological expertise spans longitudinal machine learning, meta-analysis of educational outcomes, and analysis of non-traditional data sources like mobile money records. Recent publications demonstrate consistent application of machine learning to educational psychology (2024-2025), migration risk assessment (2022), and consumer behavior (2020). Her work shows increasing emphasis on ethical AI applications in social science with publications in high-impact journals including Psychological Bulletin , PNAS , and Journal of Educational Psychology . Research collaborations span Tanzania, Germany, and the UK, with particular focus on urban migration risks and educational data science. Her work has been referenced in policy sources and gained significant attention across academic social media platforms including X and Bluesky.
